• Catalog Home
  • MY AANP
  • Help Center
Browse by
Delivery Type browse by
  • Calendar

  • Accredited Podcast (20)
  • Certificate (2)
  • OnDemand (115)
  • Publication (10)
  • Zoom Webinar (1,000) (1)
  • Multi-Module (12)
     
Hello, Guest
Sign in Browse By
  • Sign In
    New Customer? Start Here

  • Frequently Asked Questions
0
Cart
loading...
Event Date Search
  
Postal Code Search
   
Speaker Search
Credits Search
  • Home
  • »
  • Dermatology 
  • »
  • Product Details
You must select a location to proceed.
Yes
No
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration Loading Image Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
OnDemand

The Itch Factor: Understanding and Alleviating Pruritus in Dermatological Conditions


Credit(s): 1.5 Contact Hour(s) of CE; 0.5 of which may be applied towards Pharmacology
Program Number: 25027069
Original Program Date: February 24, 2025
Duration: 1 hour 19 minutes
Access: Available until February 28, 2026
  • Facebook
  • LinkedIn
  • X
  • E-Mail
    • Description
    • Sessions
    • Credits
    • Faculty
    • Materials
    • Reviews
    • Dates and Locations
    rating
    (7163)
    Read Reviews
    Category: Dermatology, [Free CE for AANP Members], Cert Exam Domain - Assessment ... (show more)
    Category: Dermatology, [Free CE for AANP Members], Cert Exam Domain - Assessment, Cert Exam Domain - Evaluation, Integumentary, Primary Care (show less)
    Subcategory: Assessment, New Treatment, Pharmacology ...(show more)
    Subcategory: Assessment, New Treatment, Pharmacology, Treatment Plan
    (show less)
    Released:   02/24/2025
    Expires:     02/28/2026 (subject to change)    
       
    • CE for this activity will not be available after this date. 

     This activity includes closed captioning.


    Overview   
    Atopic dermatitis (AD) and prurigo nodularis (PN) can be incredibly frustrating for both patients and practitioners. This activity cuts to the chase, focusing on the one symptom that dominates these conditions: itch! This program equips you with the knowledge and tools to make itch a primary target in your treatment plans, helping you break the itch-scratch cycle and significantly improve your patients' quality of life. 
     
      

    Objectives   
    • Identify the substantial clinical gravity and patient-centric burden of itch in patients with prurigo nodularis (PN) or atopic dermatitis (AD) and its key role as a therapeutic target in these diseases.
    • Recommend itch assessment and severity evaluation tools in patients with PN or AD to inform treatment decisions at baseline and measure therapeutic responsiveness longitudinally.
    • Design evidence-driven treatment plans for patients with PN or AD that employ best practices for itch assessment at baseline and longitudinal evaluation of itch-related treatment efficacy.


    Speakers   
    Leigh Ann Pansch, MSN, FNP-BC, DCNP
    Stephanie Simmerman
    , DNP, APRN
     

    Disclosure   
    This program was planned in accordance with AANP CE Standards and Policies.   

    The speakers have the following disclosures: 
    • Leigh Ann Pansch
      • Speaker Bureau: AbbVie, Amgen, Boehringer-Ingelheim, BMS, Beiersdorf, Galderma, Johnson & Johnson, Eli Lilly, Sanofi and Regeneron, UCB
    • Stephanie Simmerman
      • Speaker Bureau: Regeneron/Sanofi, AbbVie, Dermavant, Acrutis (AD, PSO, PN)

    All Planners involved in this activity have no relevant financial relationships to disclose.    

    This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.



    Disclaimer   
    Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.



    CE Credit Instructions
    • Read this activity description, including objectives and disclosures.
    • Take pretest.
    • Complete the educational content:
      • Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
      • Click on the Additional Resources button to review all additional materials provided (slide handouts and any other downloadable resources).
    • After completing all content, click on the blue Next Steps button:
      • Take post-test.
      • Submit the evaluation to receive full AANP CE/Rx credit.


    Additional Information   
    For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance. 
       
     
    1.5 Contact Hour(s) of CE,
    0.5 of which may be applied towards Pharmacology

    Purchase Options

    Register Now
    Already Registered
    Have a Question?
    See our FAQ's
    Privacy Policy
    CCPA & GDPR
    Contact us at (877) 880-1335
    Email Us